Bioscience behind tackling superbugs

January 2008

Including:

Understanding the enemy: Staphylococcus aureus, Clostridium difficile, targeting the bad guys, and encouraging the good guys
How bacteria respond to antibiotics and develop resistance: assessing the threat of new resistant strains, cell wall defences and multi-drug pumps, on the defensive, and unravelling the mysterious resistance of the bacteria that cause TB
Towards new treatments: new lease of life for penicillins, harnessing nature's antibiotic factories, a treatment from bullfrogs, EU consortium for antibiotic research, mupirocins, using weapons from viruses that kill bacteria, antimicrobial coatings, and new target for novel therapeutics
New companies take up the fight: ABsynth Biologics, Inspiralis Ltd, Novacta Biosystems Ltd, Procarta Biosystems Ltd, and Prolysis

Tracey Duncombe
tracey.duncombe@bbsrc.ac.uk
tel: 01793 414695
fax: 01793 413382